The American Cancer Society predicts that this year 161,360 will learn that they have prostate cancer. All men should have regular Prostate Specific Antigen (PSA) screenings beginning at 40. Especially those who fall into the high-risk category African Americans and those who may have a genetic predisposition to prostate cancer based on a family history of the disease. Sign-up sites are http://www.prostatepeptalk.com/ and http://www.healthtestingcenters.com/prostate-pep-talk
Cancer Treatment Centers of America (CTCA) in conjunction with LabCorp and National Football League Alumni Association (NFLA) are launching an initiative to encourage men who meet certain criteria to get screened for prostate cancer. From September 1st until October 15th of this year 2,000 men can avail themselves of a free PSA screening at 1,750 Lab Corp. sites across the US.
After the first 2,000 spots are filled men who qualify can sign-up for a PSA screening costing $25.00. There are two important conditions, you must satisfy to receive the discounted screenings. You need to register between September 1st and October 15th and the screening must be conducted no later than six months after you had signed up.
Based in Boca Raton, Florida Cancer Treatment Centers of America continually receives the highest patient satisfaction scores of similar treatment facilities in the United States. Consumer surveys rank CTCA as one of the “most admired hospital systems in the country”. Their approach to cancer care is patient-centered addressing both the physical and psychological aspects of cancer.
CTA’s success rate is in part because of their utilization of genomic testing. Genomic Testing uses a cancer cell’s genetic profile to pinpoint mutations within the cancer cell. Genomic testing has proven invaluable in determining the right course of treatment for a particular patient. Surgery, radiation, immunotherapy, and chemotherapy are used in conjunction with methods to improve quality of life during treatment.